Maternal obesity, lipotoxicity and cardiovascular diseases in offspring

Journal of Molecular and Cellular Cardiology

Volumn 55, Issue 1, 2013, Pages 111-116

  Dong, Maolong ^a,b   Zheng, Qijun ^a   Ford, Stephen P ^b   Nathanielsz, Peter W ^c   Ren, Jun ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WYOMING   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cardiovascular diseases; Insulin resistance; Maternal obesity; Obesity

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; TRIACYLGLYCEROL;

AFRICAN AMERICAN; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CAUCASIAN; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENERGY BALANCE; GENETIC DISORDER; GLUCOSE METABOLISM; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN METABOLISM; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPID TRANSPORT; LIPOTOXICITY; MATERNAL NUTRITION; MATERNAL OBESITY; METABOLIC DISORDER; NONHUMAN; OVERNUTRITION; OXIDATIVE STRESS; PERINATAL MORBIDITY; PREGNANCY DIABETES MELLITUS; PRIMATE; PRIORITY JOURNAL; PROGENY; REVIEW; RODENT; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; CARDIOVASCULAR DISEASES; ENERGY METABOLISM; FEMALE; HUMANS; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

PRIMATES; RODENTIA;

EID: 84872686599     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.08.023     Document Type: Review

References (68)

1. Ogden C.L., Carroll M.D., McDowell M.A., Flegal K.M. Obesity among adults in the United States-no statistically significant chance since 2003-2004. NCHS Data Brief 2007, 1-8.
2. Mitchell N.S., Catenacci V.A., Wyatt H.R., Hill J.O. Obesity: overview of an epidemic. Psychiatr Clin North Am 2011, 34:717-732.
3. Cornier M.A., Marshall J.A., Hill J.O., Maahs D.M., Eckel R.H. Prevention of overweight/obesity as a strategy to optimize cardiovascular health. Circulation 2011, 124:840-850.
4. Choquet H., Meyre D. Molecular basis of obesity: current status and future prospects. Curr Genomics 2011, 12:154-168.
5. Nyenwe E.A., Dagogo-Jack S. Metabolic syndrome, prediabetes and the science of primary prevention. Minerva Endocrinol 2011, 36:129-145.
6. Stanley W.C., Dabkowski E.R., Ribeiro R.F., O'Connell K.A. Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res 2012, 110:764-776.
7. Ren J., Kelley R.O. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Obesity (Silver Spring) 2009, 17:1114-1123.
8. De Divitiis O., Fazio S., Petitto M., Maddalena G., Contaldo F., Mancini M. Obesity and cardiac function. Circulation 1981, 64:477-482.
9. Zhou Y.-T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci 2000, 97:1784-1789.
10. Ren J., Sowers J.R., Walsh M.F., Brown R.A. Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol 2000, 279:H1708-H1714.
11. Ren J., Pulakat L., Whaley-Connell A., Sowers J.R. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med (Berl) 2010, 88:993-1001.
12. Moscat J., Diaz-Meco M.T. Feedback on fat: p62-mTORC1-autophagy connections. Cell 2011, 147:724-727.
13. Goldberg I.J., Trent C.M., Schulze P.C. Lipid metabolism and toxicity in the heart. Cell Metab 2012, 15:805-812.
14. de Souza C.J., Eckhardt M., Gagen K., Dong M., Chen W., Laurent D., et al. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001, 50:1863-1871.
15. Dong F., Ford S.P., Nijland M.J., Nathanielsz P.W., Ren J. Influence of maternal undernutrition and overfeeding on cardiac ciliary neurotrophic factor receptor and ventricular size in fetal sheep. J Nutr Biochem 2008, 19:409-414.
16. Ford S.P., Long N.M. Evidence for similar changes in offspring phenotype following either maternal undernutrition or overnutrition: potential impact on fetal epigenetic mechanisms. Reprod Fertil Dev 2011, 24:105-111.
17. George L.A., Zhang L., Tuersunjiang N., Ma Y., Long N.M., Uthlaut A.B., et al. Early maternal undernutrition programs increased feed intake, altered glucose metabolism and insulin secretion, and liver function in aged female offspring. Am J Physiol Regul Integr Comp Physiol 2012, 302:R795-R804.
18. Bentham J., Michell A.C., Lockstone H., Andrew D., Schneider J.E., Brown N.A., et al. Maternal high-fat diet interacts with embryonic Cited2 genotype to reduce Pitx2c expression and enhance penetrance of left-right patterning defects. Hum Mol Genet 2010, 19:3394-3401.
19. Hales C.N., Barker D.J., Clark P.M., Cox L.J., Fall C., Osmond C., et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991, 303:1019-1022.
20. Rankin J., Tennant P.W., Stothard K.J., Bythell M., Summerbell C.D., Bell R. Maternal body mass index and congenital anomaly risk: a cohort study. Int J Obes (Lond) 2010, 34:1371-1380.
21. Sullivan E.L., Smith M.S., Grove K.L. Perinatal exposure to high-fat diet programs energy balance, metabolism and behavior in adulthood. Neuroendocrinology 2011, 93:1-8.
22. Bouanane S., Merzouk H., Benkalfat N.B., Soulimane N., Merzouk S.A., Gresti J., et al. Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams. Metabolism 2010, 59:1701-1709.
23. Barker D.J., Bagby S.P., Hanson M.A. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2006, 2:700-707.
24. Long N.M., Tousley C.B., Underwood K.R., Paisley S.I., Means W.J., Hess B.W., et al. Effects of early- to mid-gestational undernutrition with or without protein supplementation on offspring growth, carcass characteristics, and adipocyte size in beef cattle. J Anim Sci 2012, 90:197-206.
25. Barker D.J. Obesity and early life. Obes Rev 2007, 8(Suppl. 1):45-49.
26. Risbridger G.P., Drummond A.E., Wlodek M. Reproduction, development, and the early origins of adult disease. Cell Tissue Res 2005, 322:3.
27. Whorwood C.B., Firth K.M., Budge H., Symonds M.E. Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11beta-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin ii receptor in neonatal sheep. Endocrinology 2001, 142:2854-2864.
28. Ponzio B.F., Carvalho M.H., Fortes Z.B., do Carmo Franco M. Implications of maternal nutrient restriction in transgenerational programming of hypertension and endothelial dysfunction across F1-F3 offspring. Life Sci 2012, 90:571-577.
29. Wang J., Ma H., Tong C., Zhang H., Lawlis G.B., Li Y., et al. Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. FASEB J 2010, 24:2066-2076.
30. Han H., Hansen T.R., Berg B., Hess B.W., Ford S.P. Maternal undernutrition induces differential cardiac gene expression in pulmonary hypertensive steers at high elevation. Am J Physiol Heart Circ Physiol 2008, 295:H382-H389.
31. Bertrand L., Horman S., Beauloye C., Vanoverschelde J.L. Insulin signalling in the heart. Cardiovasc Res 2008, 79:238-248.
32. Algahim M.F., Sen S., Taegtmeyer H. Bariatric surgery to unload the stressed heart: a metabolic hypothesis. Am J Physiol Heart Circ Physiol 2012, 302:H1539-H1545.
33. Medina-Gomez G., Gray S., Vidal-Puig A. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr 2007, 10:1132-1137.
34. Jarvie E., Hauguel-de-Mouzon S., Nelson S.M., Sattar N., Catalano P.M., Freeman D.J. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond) 2010, 119:123-129.
35. McCurdy C.E., Bishop J.M., Williams S.M., Grayson B.E., Smith M.S., Friedman J.E., et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009, 119:323-335.
36. Jungheim E.S., Louden E.D., Chi M.M., Frolova A.I., Riley J.K., Moley K.H. Preimplantation exposure of mouse embryos to palmitic acid results in fetal growth restriction followed by catch-up growth in the offspring. Biol Reprod 2011, 85:678-683.
37. Du M., Yan X., Tong J.F., Zhao J., Zhu M.J. Maternal obesity, inflammation, and fetal skeletal muscle development. Biol Reprod 2010, 82:4-12.
38. Long N.M., Rule D.C., Zhu M.J., Nathanielsz P.W., Ford S.P. Maternal obesity upregulates fatty acid and glucose transporters and increases expression of enzymes mediating fatty acid biosynthesis in fetal adipose tissue depots. J Anim Sci 2012, 90:2201-2210.
39. Stewart F.M., Freeman D.J., Ramsay J.E., Greer I.A., Caslake M., Ferrell W.R. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007, 92:969-975.
40. Lindstrom J., Peltonen M., Tuomilehto J. Lifestyle strategies for weight control: experience from the Finnish Diabetes Prevention Study. Proc Nutr Soc 2005, 64:81-88.
41. Ray J.G., Schull M.J., Kingdom J.C., Vermeulen M.J. Heart failure and dysrhythmias after maternal placental syndromes: HAD MPS Study. Heart 2012, 98:1136-1141.
42. Lopez-Jaramillo P., Lahera V., Lopez-Lopez J. Epidemic of cardiometabolic diseases: a Latin American point of view. Ther Adv Cardiovasc Dis 2011, 5:119-131.
43. Bouabdallaoui N., de Groote P., Mouquet F. Peripartum cardiomyopathy. Presse Med 2009, 38:995-1000.
44. Eckmann-Scholz C., Hoffmann U., Kramer H.H., Schollmeyer T., Christian S., Jonat W., et al. Perinatal management of pregnancies with severe fetal heart defects and epigenetic aspects. J Matern Fetal Neonatal Med 2012, [Jul 13, Electronic publication ahead of print].
45. Di Cianni G., Miccoli R., Volpe L., Lencioni C., Ghio A., Giovannitti M.G., et al. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 2005, 22:21-25.
46. Khan N.A. Role of lipids and fatty acids in macrosomic offspring of diabetic pregnancy. Cell Biochem Biophys 2007, 48:79-88.
47. Chokshi A., Drosatos K., Cheema F.H., Ji R., Khawaja T., Yu S., et al. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 2012, 125:2844-2853.
48. Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabet Med 2009, 26:1185-1192.
49. Ellis B.A., Poynten A., Lowy A.J., Furler S.M., Chisholm D.J., Kraegen E.W., et al. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 2000, 279:E554-E560.
50. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002, 277:50230-50236.
51. Schmitz-Peiffer C., Craig D.L., Biden T.J. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999, 274:24202-24210.
52. Boden G., She P., Mozzoli M., Cheung P., Gumireddy K., Reddy P., et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 2005, 54:3458-3465.
53. Oliva K., Barker G., Riley C., Bailey M.J., Permezel M., Rice G.E., et al. The effect of pre-existing maternal obesity on the placental proteome: two-dimensional difference gel electrophoresis coupled with mass spectrometry. J Mol Endocrinol 2012, 48:139-149.
54. Sen S., Simmons R.A. Maternal antioxidant supplementation prevents adiposity in the offspring of Western diet-fed rats. Diabetes 2010, 59:3058-3065.
55. Vickers M.H. Developmental programming and adult obesity: the role of leptin. Curr Opin Endocrinol Diabetes Obes 2007, 14:17-22.
56. Yu Z., Han S., Cao X., Zhu C., Wang X., Guo X. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring) 2012, 20:396-406.
57. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
58. Vazzana N., Santilli F., Sestili S., Cuccurullo C., Davi G. Determinants of increased cardiovascular disease in obesity and metabolic syndrome. Curr Med Chem 2011, 18:5267-5280.
59. Ramsay J.E., Ferrell W.R., Crawford L., Wallace A.M., Greer I.A., Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002, 87:4231-4237.
60. King J.C. Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr 2006, 26:271-291.
61. Boney C.M., Verma A., Tucker R., Vohr B.R. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005, 115:e290-e296.
62. Friedrichs G.S., Swillo R.E., Jow B., Bridal T., Numann R., Warner L.M., et al. Sphingosine modulates myocyte electrophysiology, induces negative inotropy, and decreases survival after myocardial ischemia. J Cardiovasc Pharmacol 2002, 39:18-28.
63. Oral H., Dorn G.W., Mann D.L. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 1997, 272:4836-4842.
64. de Luis D.A., Perez Castrillon J.L., Duenas A. Leptin and obesity. Minerva Med 2009, 100:229-236.
65. Turdi S., Ge W., Hu N., Bradley K.M., Ren J. Maternal and postnatal high-fat diet interaction leads to greater risk of myocardial dysfunction in offspring via obesity-induced lipotoxicity, IRS-1 serine phosphorylation and mitochondrial defects (abstract). Circulation 2011, 124:A18063.
66. Toleikyte I., Retterstol K., Leren T.P., Iversen P.O. Pregnancy outcomes in familial hypercholesterolemia: a registry-based study. Circulation 2011, 124:1606-1614.
67. Strakovsky R.S., Pan Y.X. A decrease in DKK1, a WNT inhibitor, contributes to placental lipid accumulation in an obesity-prone rat model. Biol Reprod 2012, 86:81.
68. Jyrkka J., Mursu J., Enlund H., Lonnroos E. Polypharmacy and nutritional status in elderly people. Curr Opin Clin Nutr Metab Care 2012, 15:1-6.